nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—Phenylpropanolamine—obesity	0.134	0.384	CrCtD
Ephedrine—Phentermine—obesity	0.114	0.326	CrCtD
Ephedrine—Methamphetamine—obesity	0.101	0.291	CrCtD
Ephedrine—BCHE—obesity	0.0634	0.538	CbGaD
Ephedrine—ADRB2—obesity	0.0545	0.462	CbGaD
Ephedrine—SLC18A2—Benzphetamine—obesity	0.0406	0.186	CbGbCtD
Ephedrine—SLC18A2—Methamphetamine—obesity	0.0325	0.149	CbGbCtD
Ephedrine—SLC6A2—Diethylpropion—obesity	0.0195	0.0894	CbGbCtD
Ephedrine—Etomidate—Diethylpropion—obesity	0.0181	0.0775	CrCrCtD
Ephedrine—SLC6A2—Phendimetrazine—obesity	0.0148	0.0678	CbGbCtD
Ephedrine—SLC6A2—Sibutramine—obesity	0.0148	0.0678	CbGbCtD
Ephedrine—ADRB2—Phenylpropanolamine—obesity	0.0128	0.0586	CbGbCtD
Ephedrine—ADRA1A—Phendimetrazine—obesity	0.0128	0.0586	CbGbCtD
Ephedrine—Metaraminol—Phenylpropanolamine—obesity	0.0127	0.0544	CrCrCtD
Ephedrine—SLC6A2—Phentermine—obesity	0.0112	0.0514	CbGbCtD
Ephedrine—SLC6A2—Benzphetamine—obesity	0.0112	0.0514	CbGbCtD
Ephedrine—SLC6A2—Phenylpropanolamine—obesity	0.0107	0.049	CbGbCtD
Ephedrine—ADRA1A—Benzphetamine—obesity	0.00969	0.0444	CbGbCtD
Ephedrine—SLC6A2—Bupropion—obesity	0.00953	0.0437	CbGbCtD
Ephedrine—Isoxsuprine—Phenylpropanolamine—obesity	0.00945	0.0405	CrCrCtD
Ephedrine—ADRA1A—Phenylpropanolamine—obesity	0.00924	0.0423	CbGbCtD
Ephedrine—SLC6A2—Methamphetamine—obesity	0.00896	0.0411	CbGbCtD
Ephedrine—Pseudoephedrine—Phenylpropanolamine—obesity	0.008	0.0343	CrCrCtD
Ephedrine—Selegiline—Diethylpropion—obesity	0.00785	0.0337	CrCrCtD
Ephedrine—Phenylpropanolamine—Phentermine—obesity	0.00757	0.0325	CrCrCtD
Ephedrine—Phenol—Phenylpropanolamine—obesity	0.00697	0.0299	CrCrCtD
Ephedrine—Pseudoephedrine—Phentermine—obesity	0.0068	0.0292	CrCrCtD
Ephedrine—Phenylpropanolamine—Methamphetamine—obesity	0.00675	0.0289	CrCrCtD
Ephedrine—Selegiline—Phentermine—obesity	0.00648	0.0278	CrCrCtD
Ephedrine—Phentermine—Phenylpropanolamine—obesity	0.00644	0.0276	CrCrCtD
Ephedrine—Bethanidine—Phentermine—obesity	0.00619	0.0266	CrCrCtD
Ephedrine—Pseudoephedrine—Methamphetamine—obesity	0.00606	0.026	CrCrCtD
Ephedrine—Benzyl alcohol—Phenylpropanolamine—obesity	0.00598	0.0257	CrCrCtD
Ephedrine—Mephentermine—Phentermine—obesity	0.00593	0.0254	CrCrCtD
Ephedrine—Phenol—Phentermine—obesity	0.00593	0.0254	CrCrCtD
Ephedrine—Selegiline—Methamphetamine—obesity	0.00578	0.0248	CrCrCtD
Ephedrine—Bethanidine—Methamphetamine—obesity	0.00552	0.0237	CrCrCtD
Ephedrine—Dextroamphetamine—Diethylpropion—obesity	0.00542	0.0233	CrCrCtD
Ephedrine—Amphetamine—Diethylpropion—obesity	0.00542	0.0233	CrCrCtD
Ephedrine—Phenol—Methamphetamine—obesity	0.00528	0.0227	CrCrCtD
Ephedrine—Mephentermine—Methamphetamine—obesity	0.00528	0.0227	CrCrCtD
Ephedrine—Methamphetamine—Diethylpropion—obesity	0.00527	0.0226	CrCrCtD
Ephedrine—Dextroamphetamine—Phenylpropanolamine—obesity	0.00526	0.0226	CrCrCtD
Ephedrine—Amphetamine—Phenylpropanolamine—obesity	0.00526	0.0226	CrCrCtD
Ephedrine—Methamphetamine—Phenylpropanolamine—obesity	0.00511	0.0219	CrCrCtD
Ephedrine—Benzyl alcohol—Phentermine—obesity	0.00509	0.0218	CrCrCtD
Ephedrine—Phentermine—Methamphetamine—obesity	0.00488	0.0209	CrCrCtD
Ephedrine—Selegiline—Benzphetamine—obesity	0.00458	0.0196	CrCrCtD
Ephedrine—Benzyl alcohol—Methamphetamine—obesity	0.00454	0.0195	CrCrCtD
Ephedrine—Amphetamine—Phentermine—obesity	0.00448	0.0192	CrCrCtD
Ephedrine—Dextroamphetamine—Phentermine—obesity	0.00448	0.0192	CrCrCtD
Ephedrine—Methamphetamine—Phentermine—obesity	0.00435	0.0186	CrCrCtD
Ephedrine—Dextroamphetamine—Methamphetamine—obesity	0.00399	0.0171	CrCrCtD
Ephedrine—Amphetamine—Methamphetamine—obesity	0.00399	0.0171	CrCrCtD
Ephedrine—Amphetamine—Benzphetamine—obesity	0.00316	0.0136	CrCrCtD
Ephedrine—Dextroamphetamine—Benzphetamine—obesity	0.00316	0.0136	CrCrCtD
Ephedrine—Methamphetamine—Benzphetamine—obesity	0.00307	0.0132	CrCrCtD
Ephedrine—Atomoxetine—Benzphetamine—obesity	0.00263	0.0113	CrCrCtD
Ephedrine—BCHE—diaphragm—obesity	0.00172	0.204	CbGeAlD
Ephedrine—SLC6A2—sympathetic nervous system—obesity	0.00138	0.163	CbGeAlD
Ephedrine—SLC6A2—autonomic nervous system—obesity	0.000926	0.11	CbGeAlD
Ephedrine—ACHE—islet of Langerhans—obesity	0.000424	0.0503	CbGeAlD
Ephedrine—ADRA1A—hindbrain—obesity	0.000363	0.043	CbGeAlD
Ephedrine—Psychotic disorder—Phenylpropanolamine—obesity	0.000333	0.00792	CcSEcCtD
Ephedrine—Cyclandelate—CES1—obesity	0.000328	0.258	CrCbGaD
Ephedrine—Irritability—Phenylpropanolamine—obesity	0.000326	0.00774	CcSEcCtD
Ephedrine—Urinary retention—Phenylpropanolamine—obesity	0.000325	0.00771	CcSEcCtD
Ephedrine—Sweating—Benzphetamine—obesity	0.000324	0.0077	CcSEcCtD
Ephedrine—Dysuria—Phendimetrazine—obesity	0.000323	0.00767	CcSEcCtD
Ephedrine—Psychotic disorder—Phentermine—obesity	0.000319	0.00758	CcSEcCtD
Ephedrine—Sweating—Phendimetrazine—obesity	0.000295	0.00702	CcSEcCtD
Ephedrine—Psychotic disorder—Diethylpropion—obesity	0.000278	0.00659	CcSEcCtD
Ephedrine—Angina pectoris—Phentermine—obesity	0.000275	0.00653	CcSEcCtD
Ephedrine—Psychotic disorder—Cimetidine—obesity	0.000264	0.00627	CcSEcCtD
Ephedrine—SLC18A2—adipose tissue—obesity	0.000264	0.0313	CbGeAlD
Ephedrine—Ventricular fibrillation—Sibutramine—obesity	0.00026	0.00618	CcSEcCtD
Ephedrine—Urinary retention—Cimetidine—obesity	0.000257	0.00611	CcSEcCtD
Ephedrine—Tremor—Methamphetamine—obesity	0.000257	0.0061	CcSEcCtD
Ephedrine—Paranoia—Bupropion—obesity	0.000255	0.00605	CcSEcCtD
Ephedrine—Agitation—Methamphetamine—obesity	0.000252	0.00598	CcSEcCtD
Ephedrine—SLC18A2—digestive system—obesity	0.000248	0.0294	CbGeAlD
Ephedrine—Tremor—Benzphetamine—obesity	0.000247	0.00588	CcSEcCtD
Ephedrine—ACHE—adrenal gland—obesity	0.000243	0.0288	CbGeAlD
Ephedrine—Agitation—Benzphetamine—obesity	0.000243	0.00577	CcSEcCtD
Ephedrine—Palpitations—Methamphetamine—obesity	0.000242	0.00575	CcSEcCtD
Ephedrine—SLC6A2—respiratory system—obesity	0.000238	0.0282	CbGeAlD
Ephedrine—SLC18A2—adrenal gland—obesity	0.000237	0.028	CbGeAlD
Ephedrine—Hallucination—Phenylpropanolamine—obesity	0.000235	0.00558	CcSEcCtD
Ephedrine—Palpitations—Benzphetamine—obesity	0.000233	0.00554	CcSEcCtD
Ephedrine—Dysuria—Diethylpropion—obesity	0.00023	0.00546	CcSEcCtD
Ephedrine—Tremor—Phendimetrazine—obesity	0.000226	0.00536	CcSEcCtD
Ephedrine—Hallucination—Phentermine—obesity	0.000225	0.00534	CcSEcCtD
Ephedrine—Agitation—Phendimetrazine—obesity	0.000221	0.00525	CcSEcCtD
Ephedrine—Tachycardia—Methamphetamine—obesity	0.000218	0.00518	CcSEcCtD
Ephedrine—Amphetamine—CARTPT—obesity	0.000213	0.167	CrCbGaD
Ephedrine—Palpitations—Phendimetrazine—obesity	0.000213	0.00505	CcSEcCtD
Ephedrine—Arrhythmia—Phenylpropanolamine—obesity	0.000211	0.00501	CcSEcCtD
Ephedrine—Tachycardia—Benzphetamine—obesity	0.00021	0.005	CcSEcCtD
Ephedrine—Pallor—Bupropion—obesity	0.000209	0.00497	CcSEcCtD
Ephedrine—Hyperhidrosis—Benzphetamine—obesity	0.000208	0.00495	CcSEcCtD
Ephedrine—Extrasystoles—Bupropion—obesity	0.000206	0.0049	CcSEcCtD
Ephedrine—Anorexia—Benzphetamine—obesity	0.000205	0.00488	CcSEcCtD
Ephedrine—SLC18A2—endocrine gland—obesity	0.000205	0.0243	CbGeAlD
Ephedrine—Insomnia—Methamphetamine—obesity	0.000202	0.0048	CcSEcCtD
Ephedrine—Tension—Phenylpropanolamine—obesity	0.000202	0.00479	CcSEcCtD
Ephedrine—Delirium—Bupropion—obesity	0.000202	0.00479	CcSEcCtD
Ephedrine—Nervousness—Phenylpropanolamine—obesity	0.0002	0.00474	CcSEcCtD
Ephedrine—Blood pressure increased—Sibutramine—obesity	0.000199	0.00473	CcSEcCtD
Ephedrine—BCHE—respiratory system—obesity	0.000197	0.0233	CbGeAlD
Ephedrine—Dyspepsia—Methamphetamine—obesity	0.000197	0.00467	CcSEcCtD
Ephedrine—Insomnia—Benzphetamine—obesity	0.000195	0.00463	CcSEcCtD
Ephedrine—Tension—Phentermine—obesity	0.000193	0.00459	CcSEcCtD
Ephedrine—Tremor—Phenylpropanolamine—obesity	0.000193	0.00458	CcSEcCtD
Ephedrine—Tachycardia—Phendimetrazine—obesity	0.000192	0.00455	CcSEcCtD
Ephedrine—Nervousness—Phentermine—obesity	0.000191	0.00454	CcSEcCtD
Ephedrine—Bradycardia—Cimetidine—obesity	0.00019	0.00452	CcSEcCtD
Ephedrine—Hyperhidrosis—Phendimetrazine—obesity	0.00019	0.00451	CcSEcCtD
Ephedrine—Dyspepsia—Benzphetamine—obesity	0.00019	0.00451	CcSEcCtD
Ephedrine—Agitation—Phenylpropanolamine—obesity	0.000189	0.00449	CcSEcCtD
Ephedrine—Decreased appetite—Benzphetamine—obesity	0.000187	0.00445	CcSEcCtD
Ephedrine—Anorexia—Phendimetrazine—obesity	0.000187	0.00445	CcSEcCtD
Ephedrine—Hallucination—Cimetidine—obesity	0.000186	0.00442	CcSEcCtD
Ephedrine—SLC18A2—liver—obesity	0.000185	0.0219	CbGeAlD
Ephedrine—Tremor—Phentermine—obesity	0.000184	0.00438	CcSEcCtD
Ephedrine—Agitation—Phentermine—obesity	0.000181	0.0043	CcSEcCtD
Ephedrine—Insomnia—Phendimetrazine—obesity	0.000178	0.00422	CcSEcCtD
Ephedrine—Arrhythmia—Diethylpropion—obesity	0.000176	0.00417	CcSEcCtD
Ephedrine—Anxiety—Phenylpropanolamine—obesity	0.000174	0.00414	CcSEcCtD
Ephedrine—Palpitations—Phentermine—obesity	0.000174	0.00413	CcSEcCtD
Ephedrine—Blood pressure increased—Bupropion—obesity	0.000174	0.00412	CcSEcCtD
Ephedrine—Euphoric mood—Sibutramine—obesity	0.000171	0.00406	CcSEcCtD
Ephedrine—Decreased appetite—Phendimetrazine—obesity	0.000171	0.00406	CcSEcCtD
Ephedrine—Hypertension—Phentermine—obesity	0.00017	0.00404	CcSEcCtD
Ephedrine—ADRA1A—cardiovascular system—obesity	0.00017	0.0201	CbGeAlD
Ephedrine—Confusional state—Phenylpropanolamine—obesity	0.000169	0.00402	CcSEcCtD
Ephedrine—Tension—Diethylpropion—obesity	0.000168	0.00399	CcSEcCtD
Ephedrine—Chest pain—Phentermine—obesity	0.000168	0.00398	CcSEcCtD
Ephedrine—Nervousness—Diethylpropion—obesity	0.000166	0.00395	CcSEcCtD
Ephedrine—Tachycardia—Phenylpropanolamine—obesity	0.000164	0.00389	CcSEcCtD
Ephedrine—Paranoia—Topiramate—obesity	0.000162	0.00385	CcSEcCtD
Ephedrine—Tremor—Diethylpropion—obesity	0.00016	0.00381	CcSEcCtD
Ephedrine—Agitation—Diethylpropion—obesity	0.000157	0.00374	CcSEcCtD
Ephedrine—Tachycardia—Phentermine—obesity	0.000157	0.00372	CcSEcCtD
Ephedrine—Insomnia—Phenylpropanolamine—obesity	0.000152	0.00361	CcSEcCtD
Ephedrine—Palpitations—Diethylpropion—obesity	0.000151	0.00359	CcSEcCtD
Ephedrine—BCHE—cardiovascular system—obesity	0.000151	0.0179	CbGeAlD
Ephedrine—Agitation—Cimetidine—obesity	0.00015	0.00356	CcSEcCtD
Ephedrine—Dyspnoea—Phenylpropanolamine—obesity	0.00015	0.00355	CcSEcCtD
Ephedrine—ADRA1A—adipose tissue—obesity	0.00015	0.0177	CbGeAlD
Ephedrine—Euphoric mood—Bupropion—obesity	0.000149	0.00354	CcSEcCtD
Ephedrine—Dizziness—Methamphetamine—obesity	0.000148	0.00351	CcSEcCtD
Ephedrine—Atomoxetine—NPY1R—obesity	0.000147	0.116	CrCbGaD
Ephedrine—Chest pain—Diethylpropion—obesity	0.000146	0.00346	CcSEcCtD
Ephedrine—Insomnia—Phentermine—obesity	0.000145	0.00345	CcSEcCtD
Ephedrine—Anxiety—Diethylpropion—obesity	0.000145	0.00345	CcSEcCtD
Ephedrine—SLC6A2—adrenal gland—obesity	0.000144	0.0171	CbGeAlD
Ephedrine—Dizziness—Benzphetamine—obesity	0.000143	0.00339	CcSEcCtD
Ephedrine—Dyspepsia—Phentermine—obesity	0.000141	0.00336	CcSEcCtD
Ephedrine—Psychotic disorder—Sibutramine—obesity	0.000141	0.00335	CcSEcCtD
Ephedrine—Headache—Methamphetamine—obesity	0.00014	0.00333	CcSEcCtD
Ephedrine—Feeling abnormal—Phenylpropanolamine—obesity	0.000138	0.00329	CcSEcCtD
Ephedrine—Anxiety—Cimetidine—obesity	0.000138	0.00328	CcSEcCtD
Ephedrine—Urinary retention—Sibutramine—obesity	0.000137	0.00326	CcSEcCtD
Ephedrine—Tachycardia—Diethylpropion—obesity	0.000136	0.00324	CcSEcCtD
Ephedrine—Hyperhidrosis—Diethylpropion—obesity	0.000135	0.00321	CcSEcCtD
Ephedrine—Headache—Benzphetamine—obesity	0.000135	0.00321	CcSEcCtD
Ephedrine—ADRA1A—adrenal gland—obesity	0.000134	0.0159	CbGeAlD
Ephedrine—Confusional state—Cimetidine—obesity	0.000134	0.00318	CcSEcCtD
Ephedrine—BCHE—pituitary gland—obesity	0.000134	0.0158	CbGeAlD
Ephedrine—Pallor—Topiramate—obesity	0.000133	0.00317	CcSEcCtD
Ephedrine—BCHE—adipose tissue—obesity	0.000133	0.0158	CbGeAlD
Ephedrine—Dizziness—Phendimetrazine—obesity	0.00013	0.00309	CcSEcCtD
Ephedrine—Tachycardia—Cimetidine—obesity	0.00013	0.00308	CcSEcCtD
Ephedrine—Delirium—Topiramate—obesity	0.000129	0.00305	CcSEcCtD
Ephedrine—Nausea—Benzphetamine—obesity	0.000128	0.00304	CcSEcCtD
Ephedrine—Insomnia—Diethylpropion—obesity	0.000126	0.003	CcSEcCtD
Ephedrine—BCHE—digestive system—obesity	0.000125	0.0148	CbGeAlD
Ephedrine—SLC6A2—endocrine gland—obesity	0.000125	0.0148	CbGeAlD
Ephedrine—Dyspnoea—Diethylpropion—obesity	0.000125	0.00296	CcSEcCtD
Ephedrine—Headache—Phendimetrazine—obesity	0.000123	0.00292	CcSEcCtD
Ephedrine—Psychotic disorder—Bupropion—obesity	0.000123	0.00292	CcSEcCtD
Ephedrine—Dyspepsia—Diethylpropion—obesity	0.000123	0.00292	CcSEcCtD
Ephedrine—Angina pectoris—Sibutramine—obesity	0.000122	0.00289	CcSEcCtD
Ephedrine—Irritability—Bupropion—obesity	0.00012	0.00286	CcSEcCtD
Ephedrine—Urinary retention—Bupropion—obesity	0.00012	0.00285	CcSEcCtD
Ephedrine—BCHE—adrenal gland—obesity	0.000119	0.0141	CbGeAlD
Ephedrine—Dysuria—Sibutramine—obesity	0.000117	0.00277	CcSEcCtD
Ephedrine—Nausea—Phendimetrazine—obesity	0.000117	0.00277	CcSEcCtD
Ephedrine—ADRA1A—endocrine gland—obesity	0.000116	0.0138	CbGeAlD
Ephedrine—Asthenia—Phentermine—obesity	0.000115	0.00274	CcSEcCtD
Ephedrine—Feeling abnormal—Diethylpropion—obesity	0.000115	0.00273	CcSEcCtD
Ephedrine—Dizziness—Phenylpropanolamine—obesity	0.000111	0.00264	CcSEcCtD
Ephedrine—Feeling abnormal—Cimetidine—obesity	0.00011	0.0026	CcSEcCtD
Ephedrine—Sweating—Sibutramine—obesity	0.000107	0.00254	CcSEcCtD
Ephedrine—Vomiting—Phenylpropanolamine—obesity	0.000107	0.00253	CcSEcCtD
Ephedrine—Dizziness—Phentermine—obesity	0.000106	0.00252	CcSEcCtD
Ephedrine—Rash—Phenylpropanolamine—obesity	0.000106	0.00251	CcSEcCtD
Ephedrine—Dermatitis—Phenylpropanolamine—obesity	0.000106	0.00251	CcSEcCtD
Ephedrine—Body temperature increased—Cimetidine—obesity	0.000105	0.0025	CcSEcCtD
Ephedrine—ADRA1A—liver—obesity	0.000105	0.0124	CbGeAlD
Ephedrine—BCHE—endocrine gland—obesity	0.000103	0.0123	CbGeAlD
Ephedrine—Vomiting—Phentermine—obesity	0.000102	0.00243	CcSEcCtD
Ephedrine—Dysuria—Bupropion—obesity	0.000102	0.00242	CcSEcCtD
Ephedrine—Bradycardia—Sibutramine—obesity	0.000102	0.00242	CcSEcCtD
Ephedrine—Rash—Phentermine—obesity	0.000101	0.00241	CcSEcCtD
Ephedrine—Dermatitis—Phentermine—obesity	0.000101	0.0024	CcSEcCtD
Ephedrine—Headache—Phentermine—obesity	0.000101	0.00239	CcSEcCtD
Ephedrine—Nausea—Phenylpropanolamine—obesity	9.97e-05	0.00237	CcSEcCtD
Ephedrine—Nausea—Phentermine—obesity	9.54e-05	0.00227	CcSEcCtD
Ephedrine—Asthenia—Cimetidine—obesity	9.54e-05	0.00227	CcSEcCtD
Ephedrine—Euphoric mood—Topiramate—obesity	9.5e-05	0.00226	CcSEcCtD
Ephedrine—BCHE—liver—obesity	9.33e-05	0.0111	CbGeAlD
Ephedrine—Sweating—Bupropion—obesity	9.31e-05	0.00221	CcSEcCtD
Ephedrine—Dizziness—Diethylpropion—obesity	9.24e-05	0.00219	CcSEcCtD
Ephedrine—Arrhythmia—Sibutramine—obesity	8.93e-05	0.00212	CcSEcCtD
Ephedrine—Vomiting—Diethylpropion—obesity	8.88e-05	0.00211	CcSEcCtD
Ephedrine—Rash—Diethylpropion—obesity	8.81e-05	0.00209	CcSEcCtD
Ephedrine—Dermatitis—Diethylpropion—obesity	8.8e-05	0.00209	CcSEcCtD
Ephedrine—Dizziness—Cimetidine—obesity	8.79e-05	0.00209	CcSEcCtD
Ephedrine—Headache—Diethylpropion—obesity	8.75e-05	0.00208	CcSEcCtD
Ephedrine—Hallucination—Bupropion—obesity	8.67e-05	0.00206	CcSEcCtD
Ephedrine—Muscle spasms—Orlistat—obesity	8.65e-05	0.00205	CcSEcCtD
Ephedrine—Tension—Sibutramine—obesity	8.54e-05	0.00203	CcSEcCtD
Ephedrine—Nervousness—Sibutramine—obesity	8.45e-05	0.00201	CcSEcCtD
Ephedrine—Vomiting—Cimetidine—obesity	8.45e-05	0.00201	CcSEcCtD
Ephedrine—Rash—Cimetidine—obesity	8.38e-05	0.00199	CcSEcCtD
Ephedrine—Dermatitis—Cimetidine—obesity	8.37e-05	0.00199	CcSEcCtD
Ephedrine—Muscle spasms—Sibutramine—obesity	8.37e-05	0.00199	CcSEcCtD
Ephedrine—Headache—Cimetidine—obesity	8.33e-05	0.00198	CcSEcCtD
Ephedrine—Nausea—Diethylpropion—obesity	8.3e-05	0.00197	CcSEcCtD
Ephedrine—Tremor—Sibutramine—obesity	8.15e-05	0.00194	CcSEcCtD
Ephedrine—Vertigo—Orlistat—obesity	8.08e-05	0.00192	CcSEcCtD
Ephedrine—Agitation—Sibutramine—obesity	8e-05	0.0019	CcSEcCtD
Ephedrine—Palpitations—Orlistat—obesity	7.95e-05	0.00189	CcSEcCtD
Ephedrine—Nausea—Cimetidine—obesity	7.9e-05	0.00188	CcSEcCtD
Ephedrine—Psychotic disorder—Topiramate—obesity	7.84e-05	0.00186	CcSEcCtD
Ephedrine—Vertigo—Sibutramine—obesity	7.82e-05	0.00186	CcSEcCtD
Ephedrine—Arrhythmia—Bupropion—obesity	7.79e-05	0.00185	CcSEcCtD
Ephedrine—Palpitations—Sibutramine—obesity	7.69e-05	0.00183	CcSEcCtD
Ephedrine—Irritability—Topiramate—obesity	7.66e-05	0.00182	CcSEcCtD
Ephedrine—Chest pain—Orlistat—obesity	7.66e-05	0.00182	CcSEcCtD
Ephedrine—Urinary retention—Topiramate—obesity	7.63e-05	0.00181	CcSEcCtD
Ephedrine—Anxiety—Orlistat—obesity	7.63e-05	0.00181	CcSEcCtD
Ephedrine—Hypertension—Sibutramine—obesity	7.51e-05	0.00178	CcSEcCtD
Ephedrine—Tension—Bupropion—obesity	7.44e-05	0.00177	CcSEcCtD
Ephedrine—Chest pain—Sibutramine—obesity	7.41e-05	0.00176	CcSEcCtD
Ephedrine—Anxiety—Sibutramine—obesity	7.38e-05	0.00175	CcSEcCtD
Ephedrine—Nervousness—Bupropion—obesity	7.37e-05	0.00175	CcSEcCtD
Ephedrine—Muscle spasms—Bupropion—obesity	7.29e-05	0.00173	CcSEcCtD
Ephedrine—Confusional state—Sibutramine—obesity	7.16e-05	0.0017	CcSEcCtD
Ephedrine—Tremor—Bupropion—obesity	7.11e-05	0.00169	CcSEcCtD
Ephedrine—Hyperhidrosis—Orlistat—obesity	7.09e-05	0.00169	CcSEcCtD
Ephedrine—Agitation—Bupropion—obesity	6.97e-05	0.00166	CcSEcCtD
Ephedrine—Tachycardia—Sibutramine—obesity	6.93e-05	0.00165	CcSEcCtD
Ephedrine—Hyperhidrosis—Sibutramine—obesity	6.87e-05	0.00163	CcSEcCtD
Ephedrine—Vertigo—Bupropion—obesity	6.82e-05	0.00162	CcSEcCtD
Ephedrine—Anorexia—Sibutramine—obesity	6.77e-05	0.00161	CcSEcCtD
Ephedrine—Angina pectoris—Topiramate—obesity	6.76e-05	0.00161	CcSEcCtD
Ephedrine—Palpitations—Bupropion—obesity	6.7e-05	0.00159	CcSEcCtD
Ephedrine—Insomnia—Orlistat—obesity	6.64e-05	0.00158	CcSEcCtD
Ephedrine—Hypertension—Bupropion—obesity	6.55e-05	0.00156	CcSEcCtD
Ephedrine—Etomidate—CYP19A1—obesity	6.52e-05	0.0512	CrCbGaD
Ephedrine—Dysuria—Topiramate—obesity	6.49e-05	0.00154	CcSEcCtD
Ephedrine—Dyspepsia—Orlistat—obesity	6.46e-05	0.00153	CcSEcCtD
Ephedrine—Chest pain—Bupropion—obesity	6.46e-05	0.00153	CcSEcCtD
Ephedrine—Anxiety—Bupropion—obesity	6.44e-05	0.00153	CcSEcCtD
Ephedrine—Insomnia—Sibutramine—obesity	6.42e-05	0.00153	CcSEcCtD
Ephedrine—Decreased appetite—Orlistat—obesity	6.38e-05	0.00152	CcSEcCtD
Ephedrine—Dyspnoea—Sibutramine—obesity	6.33e-05	0.0015	CcSEcCtD
Ephedrine—Pain—Orlistat—obesity	6.28e-05	0.00149	CcSEcCtD
Ephedrine—Dyspepsia—Sibutramine—obesity	6.25e-05	0.00149	CcSEcCtD
Ephedrine—Confusional state—Bupropion—obesity	6.24e-05	0.00148	CcSEcCtD
Ephedrine—Decreased appetite—Sibutramine—obesity	6.17e-05	0.00147	CcSEcCtD
Ephedrine—Pain—Sibutramine—obesity	6.07e-05	0.00144	CcSEcCtD
Ephedrine—Feeling abnormal—Orlistat—obesity	6.05e-05	0.00144	CcSEcCtD
Ephedrine—Tachycardia—Bupropion—obesity	6.04e-05	0.00144	CcSEcCtD
Ephedrine—Hyperhidrosis—Bupropion—obesity	5.99e-05	0.00142	CcSEcCtD
Ephedrine—Anorexia—Bupropion—obesity	5.9e-05	0.0014	CcSEcCtD
Ephedrine—Feeling abnormal—Sibutramine—obesity	5.85e-05	0.00139	CcSEcCtD
Ephedrine—Body temperature increased—Orlistat—obesity	5.8e-05	0.00138	CcSEcCtD
Ephedrine—Bradycardia—Topiramate—obesity	5.65e-05	0.00134	CcSEcCtD
Ephedrine—Body temperature increased—Sibutramine—obesity	5.61e-05	0.00133	CcSEcCtD
Ephedrine—Insomnia—Bupropion—obesity	5.6e-05	0.00133	CcSEcCtD
Ephedrine—Hallucination—Topiramate—obesity	5.52e-05	0.00131	CcSEcCtD
Ephedrine—Dyspnoea—Bupropion—obesity	5.52e-05	0.00131	CcSEcCtD
Ephedrine—Dyspepsia—Bupropion—obesity	5.45e-05	0.00129	CcSEcCtD
Ephedrine—Decreased appetite—Bupropion—obesity	5.38e-05	0.00128	CcSEcCtD
Ephedrine—Pain—Bupropion—obesity	5.29e-05	0.00126	CcSEcCtD
Ephedrine—Asthenia—Orlistat—obesity	5.27e-05	0.00125	CcSEcCtD
Ephedrine—Feeling abnormal—Bupropion—obesity	5.1e-05	0.00121	CcSEcCtD
Ephedrine—Asthenia—Sibutramine—obesity	5.1e-05	0.00121	CcSEcCtD
Ephedrine—Body temperature increased—Bupropion—obesity	4.89e-05	0.00116	CcSEcCtD
Ephedrine—Phenylpropanolamine—DRD1—obesity	4.87e-05	0.0383	CrCbGaD
Ephedrine—Dizziness—Orlistat—obesity	4.85e-05	0.00115	CcSEcCtD
Ephedrine—Tension—Topiramate—obesity	4.74e-05	0.00113	CcSEcCtD
Ephedrine—Dizziness—Sibutramine—obesity	4.7e-05	0.00112	CcSEcCtD
Ephedrine—Nervousness—Topiramate—obesity	4.69e-05	0.00112	CcSEcCtD
Ephedrine—Vomiting—Orlistat—obesity	4.67e-05	0.00111	CcSEcCtD
Ephedrine—Muscle spasms—Topiramate—obesity	4.65e-05	0.0011	CcSEcCtD
Ephedrine—Rash—Orlistat—obesity	4.63e-05	0.0011	CcSEcCtD
Ephedrine—Dermatitis—Orlistat—obesity	4.62e-05	0.0011	CcSEcCtD
Ephedrine—Headache—Orlistat—obesity	4.6e-05	0.00109	CcSEcCtD
Ephedrine—Tremor—Topiramate—obesity	4.53e-05	0.00108	CcSEcCtD
Ephedrine—Phenylpropanolamine—ADRB1—obesity	4.52e-05	0.0355	CrCbGaD
Ephedrine—Vomiting—Sibutramine—obesity	4.52e-05	0.00107	CcSEcCtD
Ephedrine—Rash—Sibutramine—obesity	4.48e-05	0.00106	CcSEcCtD
Ephedrine—Dermatitis—Sibutramine—obesity	4.47e-05	0.00106	CcSEcCtD
Ephedrine—Headache—Sibutramine—obesity	4.45e-05	0.00106	CcSEcCtD
Ephedrine—Asthenia—Bupropion—obesity	4.44e-05	0.00106	CcSEcCtD
Ephedrine—Agitation—Topiramate—obesity	4.44e-05	0.00106	CcSEcCtD
Ephedrine—Nausea—Orlistat—obesity	4.36e-05	0.00104	CcSEcCtD
Ephedrine—Vertigo—Topiramate—obesity	4.34e-05	0.00103	CcSEcCtD
Ephedrine—Palpitations—Topiramate—obesity	4.27e-05	0.00101	CcSEcCtD
Ephedrine—Nausea—Sibutramine—obesity	4.22e-05	0.001	CcSEcCtD
Ephedrine—Hypertension—Topiramate—obesity	4.17e-05	0.000991	CcSEcCtD
Ephedrine—Chest pain—Topiramate—obesity	4.11e-05	0.000978	CcSEcCtD
Ephedrine—Anxiety—Topiramate—obesity	4.1e-05	0.000974	CcSEcCtD
Ephedrine—Dizziness—Bupropion—obesity	4.09e-05	0.000973	CcSEcCtD
Ephedrine—Confusional state—Topiramate—obesity	3.98e-05	0.000945	CcSEcCtD
Ephedrine—Vomiting—Bupropion—obesity	3.94e-05	0.000935	CcSEcCtD
Ephedrine—Rash—Bupropion—obesity	3.9e-05	0.000927	CcSEcCtD
Ephedrine—Dermatitis—Bupropion—obesity	3.9e-05	0.000927	CcSEcCtD
Ephedrine—Headache—Bupropion—obesity	3.88e-05	0.000921	CcSEcCtD
Ephedrine—Tachycardia—Topiramate—obesity	3.85e-05	0.000915	CcSEcCtD
Ephedrine—Pseudoephedrine—ADRB1—obesity	3.82e-05	0.03	CrCbGaD
Ephedrine—Hyperhidrosis—Topiramate—obesity	3.81e-05	0.000906	CcSEcCtD
Ephedrine—Phenylpropanolamine—ADRB2—obesity	3.8e-05	0.0299	CrCbGaD
Ephedrine—Anorexia—Topiramate—obesity	3.76e-05	0.000893	CcSEcCtD
Ephedrine—Nausea—Bupropion—obesity	3.68e-05	0.000874	CcSEcCtD
Ephedrine—Pseudoephedrine—TNF—obesity	3.63e-05	0.0285	CrCbGaD
Ephedrine—Insomnia—Topiramate—obesity	3.57e-05	0.000848	CcSEcCtD
Ephedrine—Dyspnoea—Topiramate—obesity	3.52e-05	0.000835	CcSEcCtD
Ephedrine—Dyspepsia—Topiramate—obesity	3.47e-05	0.000825	CcSEcCtD
Ephedrine—Decreased appetite—Topiramate—obesity	3.43e-05	0.000815	CcSEcCtD
Ephedrine—Pain—Topiramate—obesity	3.37e-05	0.000801	CcSEcCtD
Ephedrine—Feeling abnormal—Topiramate—obesity	3.25e-05	0.000772	CcSEcCtD
Ephedrine—Pseudoephedrine—ADRB2—obesity	3.21e-05	0.0252	CrCbGaD
Ephedrine—Atomoxetine—HTR1B—obesity	3.2e-05	0.0251	CrCbGaD
Ephedrine—Body temperature increased—Topiramate—obesity	3.12e-05	0.000741	CcSEcCtD
Ephedrine—Phentermine—SLC6A4—obesity	3.08e-05	0.0242	CrCbGaD
Ephedrine—Pseudoephedrine—SLC6A4—obesity	2.92e-05	0.0229	CrCbGaD
Ephedrine—Benzyl alcohol—CYP2E1—obesity	2.84e-05	0.0223	CrCbGaD
Ephedrine—Asthenia—Topiramate—obesity	2.83e-05	0.000672	CcSEcCtD
Ephedrine—Selegiline—CYP2E1—obesity	2.73e-05	0.0214	CrCbGaD
Ephedrine—Dizziness—Topiramate—obesity	2.61e-05	0.00062	CcSEcCtD
Ephedrine—Atomoxetine—HTR2C—obesity	2.6e-05	0.0205	CrCbGaD
Ephedrine—Vomiting—Topiramate—obesity	2.51e-05	0.000596	CcSEcCtD
Ephedrine—Rash—Topiramate—obesity	2.49e-05	0.000591	CcSEcCtD
Ephedrine—Dermatitis—Topiramate—obesity	2.48e-05	0.00059	CcSEcCtD
Ephedrine—Headache—Topiramate—obesity	2.47e-05	0.000587	CcSEcCtD
Ephedrine—Amphetamine—SLC6A4—obesity	2.37e-05	0.0186	CrCbGaD
Ephedrine—Amphetamine—DRD2—obesity	2.35e-05	0.0185	CrCbGaD
Ephedrine—Nausea—Topiramate—obesity	2.34e-05	0.000557	CcSEcCtD
Ephedrine—Methamphetamine—SLC6A4—obesity	2.19e-05	0.0172	CrCbGaD
Ephedrine—Atomoxetine—SLC6A4—obesity	2.16e-05	0.017	CrCbGaD
Ephedrine—Atomoxetine—HTR2A—obesity	1.66e-05	0.013	CrCbGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—obesity	2.45e-06	8.15e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NPS—obesity	2.43e-06	8.06e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GNAS—obesity	2.43e-06	8.06e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCKAR—obesity	2.42e-06	8.05e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HRH3—obesity	2.42e-06	8.05e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—F2—obesity	2.39e-06	7.93e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PRKCB—obesity	2.39e-06	7.93e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DRD1—obesity	2.38e-06	7.91e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HTR2C—obesity	2.38e-06	7.91e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—LPL—obesity	2.37e-06	7.86e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—COMT—obesity	2.35e-06	7.81e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AGT—obesity	2.35e-06	7.79e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRKAR2B—obesity	2.33e-06	7.75e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCL5—obesity	2.32e-06	7.7e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPARGC1A—obesity	2.32e-06	7.7e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GNB3—obesity	2.32e-06	7.7e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NTRK2—obesity	2.32e-06	7.69e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GPX1—obesity	2.31e-06	7.66e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—HMOX1—obesity	2.31e-06	7.66e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ADRB1—obesity	2.31e-06	7.66e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PRKCD—obesity	2.3e-06	7.64e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CG—obesity	2.29e-06	7.59e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PARP1—obesity	2.26e-06	7.5e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GHRL—obesity	2.26e-06	7.5e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GNAS—obesity	2.26e-06	7.5e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NCF2—obesity	2.25e-06	7.48e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—HTR2A—obesity	2.25e-06	7.48e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—C3—obesity	2.25e-06	7.47e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CD36—obesity	2.25e-06	7.46e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DRD4—obesity	2.24e-06	7.44e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOB—obesity	2.21e-06	7.34e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NPY—obesity	2.2e-06	7.29e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IAPP—obesity	2.18e-06	7.25e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOC3—obesity	2.18e-06	7.25e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—POMC—obesity	2.18e-06	7.22e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PRKCB—obesity	2.17e-06	7.2e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—F2—obesity	2.17e-06	7.2e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CNR1—obesity	2.14e-06	7.1e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AGT—obesity	2.14e-06	7.1e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MTHFR—obesity	2.13e-06	7.07e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CRH—obesity	2.12e-06	7.04e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HTR1B—obesity	2.12e-06	7.04e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—LPL—obesity	2.11e-06	7.01e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TCF7L2—obesity	2.1e-06	6.97e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SDC1—obesity	2.1e-06	6.96e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT2—obesity	2.09e-06	6.94e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PRKCD—obesity	2.09e-06	6.94e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPARA—obesity	2.09e-06	6.94e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DRD2—obesity	2.09e-06	6.93e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CG—obesity	2.08e-06	6.89e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTPN1—obesity	2.07e-06	6.86e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GCG—obesity	2.07e-06	6.86e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKR1C3—obesity	2.06e-06	6.84e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GPX1—obesity	2.06e-06	6.84e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HTR2A—obesity	2.05e-06	6.79e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—C3—obesity	2.04e-06	6.78e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AGT—obesity	2.02e-06	6.72e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NPS—obesity	2.01e-06	6.67e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CD—obesity	2.01e-06	6.67e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CD36—obesity	2.01e-06	6.66e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOE—obesity	1.98e-06	6.59e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—POMC—obesity	1.98e-06	6.56e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PRKCB—obesity	1.98e-06	6.56e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—F2—obesity	1.98e-06	6.56e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PRL—obesity	1.97e-06	6.54e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HTR2C—obesity	1.97e-06	6.54e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DRD1—obesity	1.97e-06	6.54e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CAV1—obesity	1.96e-06	6.52e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOA1—obesity	1.96e-06	6.51e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STK11—obesity	1.94e-06	6.45e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AGT—obesity	1.94e-06	6.45e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCL2—obesity	1.93e-06	6.42e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PLG—obesity	1.92e-06	6.37e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—RHOA—obesity	1.92e-06	6.36e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NTRK2—obesity	1.92e-06	6.36e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADRB1—obesity	1.91e-06	6.34e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MTHFR—obesity	1.9e-06	6.31e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT2—obesity	1.9e-06	6.3e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3R1—obesity	1.9e-06	6.3e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CG—obesity	1.89e-06	6.28e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.88e-06	6.23e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FOXO3—obesity	1.87e-06	6.22e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GHRL—obesity	1.87e-06	6.2e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PARP1—obesity	1.87e-06	6.2e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPARA—obesity	1.86e-06	6.19e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DRD4—obesity	1.85e-06	6.15e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SOCS1—obesity	1.84e-06	6.11e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CD—obesity	1.82e-06	6.06e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SOCS3—obesity	1.82e-06	6.04e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AGT—obesity	1.81e-06	6e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—POMC—obesity	1.8e-06	5.97e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PRKCB—obesity	1.79e-06	5.96e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—F2—obesity	1.79e-06	5.96e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CG—obesity	1.79e-06	5.94e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GNB3—obesity	1.78e-06	5.91e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOE—obesity	1.77e-06	5.87e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CNR1—obesity	1.77e-06	5.87e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—TYK2—obesity	1.75e-06	5.83e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CAV1—obesity	1.75e-06	5.82e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CB—obesity	1.75e-06	5.81e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOA1—obesity	1.75e-06	5.81e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF2—obesity	1.75e-06	5.8e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—RHOA—obesity	1.74e-06	5.78e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TCF7L2—obesity	1.74e-06	5.77e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GNAS—obesity	1.73e-06	5.75e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT2—obesity	1.73e-06	5.74e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPARG—obesity	1.73e-06	5.74e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DRD2—obesity	1.73e-06	5.73e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3R1—obesity	1.72e-06	5.72e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CG—obesity	1.72e-06	5.7e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTPN1—obesity	1.71e-06	5.67e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GCG—obesity	1.71e-06	5.67e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—POMC—obesity	1.7e-06	5.66e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOB—obesity	1.7e-06	5.63e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—INS—obesity	1.69e-06	5.63e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.67e-06	5.56e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CD—obesity	1.66e-06	5.52e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCL5—obesity	1.66e-06	5.5e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—POMC—obesity	1.63e-06	5.42e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRL—obesity	1.63e-06	5.41e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LPL—obesity	1.62e-06	5.38e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FOXO1—obesity	1.61e-06	5.34e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STK11—obesity	1.61e-06	5.33e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RPS6KB1—obesity	1.61e-06	5.33e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCL2—obesity	1.6e-06	5.31e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CG—obesity	1.6e-06	5.3e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CB—obesity	1.59e-06	5.28e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PLG—obesity	1.59e-06	5.27e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—RHOA—obesity	1.59e-06	5.26e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CD—obesity	1.57e-06	5.22e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT2—obesity	1.57e-06	5.21e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3R1—obesity	1.57e-06	5.21e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALB—obesity	1.55e-06	5.16e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FOXO3—obesity	1.55e-06	5.15e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADRB2—obesity	1.55e-06	5.13e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPARG—obesity	1.54e-06	5.12e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SOCS1—obesity	1.52e-06	5.06e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—POMC—obesity	1.52e-06	5.05e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—INS—obesity	1.51e-06	5.02e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CD—obesity	1.51e-06	5.01e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SOCS3—obesity	1.5e-06	4.99e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PRKCD—obesity	1.49e-06	4.96e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3R1—obesity	1.49e-06	4.93e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NOS3—obesity	1.49e-06	4.93e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GNB3—obesity	1.47e-06	4.89e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HTR2A—obesity	1.46e-06	4.85e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—C3—obesity	1.46e-06	4.84e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—TYK2—obesity	1.45e-06	4.82e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CB—obesity	1.45e-06	4.81e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF2—obesity	1.45e-06	4.8e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—RHOA—obesity	1.44e-06	4.78e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GNAS—obesity	1.43e-06	4.76e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3R1—obesity	1.42e-06	4.73e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOB—obesity	1.4e-06	4.66e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CD—obesity	1.4e-06	4.66e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IRS2—obesity	1.39e-06	4.61e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AGT—obesity	1.39e-06	4.6e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALB—obesity	1.39e-06	4.6e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CB—obesity	1.37e-06	4.55e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL5—obesity	1.37e-06	4.55e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—obesity	1.36e-06	4.51e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOE—obesity	1.36e-06	4.51e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LEP—obesity	1.36e-06	4.51e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CAV1—obesity	1.35e-06	4.47e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOA1—obesity	1.34e-06	4.46e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LPL—obesity	1.34e-06	4.45e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FOXO1—obesity	1.33e-06	4.42e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RPS6KB1—obesity	1.33e-06	4.41e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3R1—obesity	1.33e-06	4.4e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NOS3—obesity	1.33e-06	4.4e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CB—obesity	1.32e-06	4.37e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ESR1—obesity	1.3e-06	4.31e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PRKCB—obesity	1.28e-06	4.25e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—F2—obesity	1.28e-06	4.25e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BAD—obesity	1.27e-06	4.2e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRKCD—obesity	1.23e-06	4.1e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CG—obesity	1.23e-06	4.07e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CB—obesity	1.22e-06	4.06e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—obesity	1.21e-06	4.03e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IRS1—obesity	1.21e-06	4.02e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HTR2A—obesity	1.21e-06	4.01e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—C3—obesity	1.21e-06	4.01e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—POMC—obesity	1.17e-06	3.87e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—INS—obesity	1.16e-06	3.85e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IRS2—obesity	1.15e-06	3.81e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AGT—obesity	1.15e-06	3.81e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCL2—obesity	1.14e-06	3.79e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LEP—obesity	1.12e-06	3.73e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOE—obesity	1.12e-06	3.73e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1—obesity	1.12e-06	3.73e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT2—obesity	1.12e-06	3.72e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CAV1—obesity	1.11e-06	3.7e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOA1—obesity	1.11e-06	3.69e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CD—obesity	1.08e-06	3.58e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ESR1—obesity	1.07e-06	3.56e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CA—obesity	1.07e-06	3.54e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SERPINE1—obesity	1.07e-06	3.54e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—F2—obesity	1.06e-06	3.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRKCB—obesity	1.06e-06	3.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BAD—obesity	1.05e-06	3.48e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TYK2—obesity	1.04e-06	3.44e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RHOA—obesity	1.03e-06	3.41e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOS3—obesity	1.02e-06	3.38e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3R1—obesity	1.02e-06	3.38e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CG—obesity	1.01e-06	3.37e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IRS1—obesity	1e-06	3.33e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CA—obesity	9.69e-07	3.22e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—POMC—obesity	9.65e-07	3.2e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—INS—obesity	9.6e-07	3.19e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL2—obesity	9.44e-07	3.14e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MTOR—obesity	9.39e-07	3.12e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CB—obesity	9.39e-07	3.12e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1—obesity	9.28e-07	3.08e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT2—obesity	9.28e-07	3.08e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CD—obesity	8.91e-07	2.96e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	8.83e-07	2.93e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SERPINE1—obesity	8.82e-07	2.93e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT1—obesity	8.72e-07	2.9e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—obesity	8.58e-07	2.85e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TYK2—obesity	8.57e-07	2.85e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RHOA—obesity	8.5e-07	2.82e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOS3—obesity	8.42e-07	2.79e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3R1—obesity	8.42e-07	2.79e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CA—obesity	8.36e-07	2.78e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—obesity	8.16e-07	2.71e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	8.02e-07	2.66e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK8—obesity	7.94e-07	2.64e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT1—obesity	7.92e-07	2.63e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MTOR—obesity	7.77e-07	2.58e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CB—obesity	7.77e-07	2.58e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CA—obesity	7.46e-07	2.48e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT3—obesity	7.26e-07	2.41e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT1—obesity	7.21e-07	2.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—obesity	7.1e-07	2.36e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AKT1—obesity	6.83e-07	2.27e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—obesity	6.75e-07	2.24e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—obesity	6.75e-07	2.24e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFB1—obesity	6.73e-07	2.23e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK8—obesity	6.57e-07	2.18e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT1—obesity	6.55e-07	2.17e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AKT1—obesity	6.09e-07	2.02e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT3—obesity	6e-07	1.99e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CA—obesity	5.73e-07	1.9e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—obesity	5.58e-07	1.85e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFB1—obesity	5.57e-07	1.85e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—obesity	5.07e-07	1.68e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CA—obesity	4.74e-07	1.57e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT1—obesity	4.68e-07	1.55e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—obesity	4.19e-07	1.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT1—obesity	3.87e-07	1.28e-05	CbGpPWpGaD
